| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| mirati kras g12c inhibitor | 0.94 | 0.7 | 5734 | 21 | 26 |
| mirati | 1.14 | 0.8 | 8053 | 61 | 6 |
| kras | 1.46 | 0.7 | 8923 | 14 | 4 |
| g12c | 1.5 | 0.9 | 2132 | 71 | 4 |
| inhibitor | 0.07 | 1 | 8342 | 85 | 9 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| mirati kras g12c inhibitor | 0.02 | 0.1 | 3917 | 55 |
| kras g12d inhibitor mirati | 0.25 | 0.2 | 3060 | 79 |
| kras g12c inhibitor 1 | 1.81 | 0.1 | 2046 | 57 |
| kras g12c on inhibitor | 1.69 | 0.7 | 8157 | 82 |
| kras g12c inhibitor drugs | 0.77 | 0.9 | 526 | 75 |
| fda approved kras g12c inhibitor | 0.33 | 0.7 | 8818 | 29 |
| kras g12c inhibitor adagrasib | 0.2 | 0.4 | 1423 | 7 |
| kras g12c inhibitor clinical trial | 1.87 | 0.3 | 470 | 50 |
| kras g12c inhibitor sotorasib | 0.49 | 0.3 | 5566 | 15 |
| kras g12c inhibitor resistance | 1.28 | 0.8 | 533 | 32 |
| kras g12c inhibitor-12 | 0.16 | 0.7 | 6027 | 34 |
| kras g12c inhibitor fda approval | 1.31 | 0.4 | 4583 | 69 |
| kras g12c inhibitor amgen | 1.89 | 0.7 | 7986 | 99 |
| the clinical kras g12c inhibitor amg 510 | 1.84 | 0.7 | 6562 | 89 |
| kras g12c inhibitor-12_1855 | 1.83 | 0.4 | 1143 | 10 |
| kras g12c covalent inhibitor | 0.41 | 0.5 | 771 | 98 |
| roche kras g12c inhibitor | 0.38 | 0.7 | 3153 | 18 |
| kras g12d inhibitor clinical trial | 0.83 | 0.1 | 4626 | 10 |
| kras g12c competitive with attgraseb drug | 0.51 | 0.3 | 9942 | 88 |
| kras g12d inhibitor amgen | 0.42 | 0.5 | 7122 | 98 |
| kras g12c clinical trial | 0.16 | 0.1 | 1895 | 93 |
| anti-kras g12d mtcr pbl | 1.66 | 0.1 | 5872 | 80 |
